	Corrigendum to "Improved clinical outcomes with low-dose anti-CTLA-4 (Nurulimab) plus anti-PD-1 (Prolgolimab) vs. anti-PD-1 monotherapy in advanced cutaneous melanoma: Results from the phase III OCTAVA trial" [Eur J Cancer. 227 (2025) 115674]. Eur J Cancer Demidov L, Samoylenko I, Kharkevich G, Orlova K, Moiseenko V, Utyashev I, Stroyakovskiy D, Kozlov V, Zimina A, Mochalova A, Demidova S, Lyadova M, Kutkovich A, Skopin P, Kovalenko N, Safina S, Volkov V, Semiletova Y, Vaschenko V, Kislov N, Poltoratskiy A, Shumskaya I, Kolomiets S, Sobolev A, Belogortsev I, Odintsova S, Rastogi S, Andabekov T, Penkov K, Semenova A, Obukhov A, Belyakovsky V, Yurchenkov A, Gladkov O, Neve R, Falaleeva N, Poddubskaya E, Vaibhav A, Kirtbaya D, Chapko Y, Smagina M, Fadeeva N, Sorokina I, Mikhailova E, Linkova Y, Zinkina-Orikhan A, Lutskii A, Gabidullin R, Rzaev R, Kryukov F. PMID: 40886565 [PubMed - as supplied by publisher]
	Semi-supervised GAN with hybrid regularization and evolutionary hyperparameter tuning for accurate melanoma detection. Sci Rep Golkarieh A, Razmara P, Lagzian A, Dolatabadi A, Mousavirad SJ. PMID: 40885789 [PubMed - indexed for MEDLINE]
	Uveal Melanoma UK national guidelines: 2023 update. Eur J Cancer Carter TJ, Broadfoot J, Coupland SE, Damato B, Evans H, Fenwick S, Khoja L, Krausa T, Lewis R, Nathan P, Modi S, Negretti G, Rashid S, Sacco JJ, Shaw H, Sisley K, Sowton R, Turajlic S, Turnbull N, Woraker A, Wheater M. PMID: 40885127 [PubMed - as supplied by publisher]
	An attention-based mRNA transformer network for accurate prediction of melanoma response to immune checkpoint inhibitors. Sci Rep Yin Y, Zhang T, Wang Z. PMID: 40883359 [PubMed - indexed for MEDLINE]
	Sun-Safety Knowledge, Attitudes and Behaviour in Western Saudi Arabia: Implications for Psycho-Oncology Prevention Services. Psychooncology Flemban AF, Kabrah SM, Alabbadi AA, Alharbi NM, Alotaibi AA, Baghdadi RA, Alhawsawi MK, Alharbi BM, Albar HT, Ekram SN, Elmoneim HMA. PMID: 40883220 [PubMed - indexed for MEDLINE]
	Randomized, Double-Blind, Phase III LEAP-003 Study of First-Line Lenvatinib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab for Unresectable or Metastatic Melanoma. Ann Oncol Arance A, Berciano-Guerrero MA, Guo J, Carlino MS, Ascierto PA, Burotto M, Mortier L, Queirolo P, Chiarion-Sileni V, Schachter J, Zhang X, Martin-Liberal J, Del Vecchio M, Okpara CE, Dutcus C, Zhang J, Diede SJ, Neff T, Long GV. PMID: 40885529 [PubMed - as supplied by publisher]
	Risk of second primary cancers among melanoma survivors following radiotherapy: A population-based cohort study. Cancer Epidemiol Ashok Kumar A, K Lam A, Gopalan V. PMID: 40882413 [PubMed - as supplied by publisher]
	Molecular Basis of BRAF Inhibitor Resistance in Melanoma: A Systematic Review. Pharmaceuticals (Basel) Cosci I, Salizzato V, Del Fiore P, Pigozzo J, Guarneri V, Mocellin S, Ferlin A, Mathlouthi S, Piccin L, Garofalo M. PMID: 40872623 [PubMed - in process]
	Tumor Microenvironmental Dynamics in Shaping Resistance to Therapeutic Interventions in Melanoma: A Narrative Review. Pharmaceuticals (Basel) Turner LM, Terhaar H, Jiminez V, Anderson BJ, Grant E, Yusuf N. PMID: 40872475 [PubMed - in process]
	Anorectal Malignant Melanoma: Diagnostic Pitfalls and Prognostic Insights from a Single-Center Retrospective Analysis. Diagnostics (Basel) Haf, Bardakç, Ergun Y, Karahan I, Bayram D, Kos FT, Alg, Bal O, Uncu D. PMID: 40870938 [PubMed - in process]
	Gene Mutation-Negative Malignant Melanoma in a Prepubertal Patient: A Clinical and Molecular Case Report. Genes (Basel) Gu, Sosnowska-Sienkiewicz P, Szyd, Kurzawa P, Januszkiewicz-Lewandowska D. PMID: 40869985 [PubMed - indexed for MEDLINE]
	Association Study of PDCD1 Gene Variants and Its Gene Expression with Cutaneous Melanoma in a Mexican Population. Genes (Basel) Valdez-Salazar F, Jiménez-Del Rio LA, Guevara-Gutiérrez E, Mendoza-Ochoa AM, Zorrilla-Marina MJ, García-Nuño DK, Padilla-Gutiérrez JR, Muñoz-Valle JF, Valdés-Alvarado E. PMID: 40869918 [PubMed - indexed for MEDLINE]
	Genetic Landscape of Familial Melanoma. Genes (Basel) Scarano C, Veneruso I, D'Argenio V. PMID: 40869905 [PubMed - indexed for MEDLINE]
	Circulating Calprotectin Distinguishes Metastatic Melanoma and Predicts Liver Metastasis. Int J Mol Sci Szász I, Koroknai V, Várvölgyi T, Emri G, Szabó IL, Balázs M. PMID: 40869349 [PubMed - indexed for MEDLINE]
	BRAF V600E Mutation Has Variable Tumor-Specific Effects on Expression of MAPK Pathway Genes That Could Affect Patient Outcome. Int J Mol Sci Darabi S, Stafford P, Braxton DR, Zuazo CE, Brodie TJ, Demeure MJ. PMID: 40869231 [PubMed - indexed for MEDLINE]
	TRP Channels in Skin Cancer: Focus on Malignant Melanoma. Int J Mol Sci Twardak D, Havryliuk V, Gagat M. PMID: 40869148 [PubMed - indexed for MEDLINE]
	Therapeutic Opportunities in Melanoma Through PRAME Expression. Biomedicines Mokos M, Prka, Ga, Brki, Pondeljak N, . PMID: 40868240 [PubMed - in process]
	Adjuvant Immunotherapy in Stage IIB/IIC Melanoma: Current Evidence and Future Directions. Biomedicines Prka, Brki, Pondeljak N, Mokos M, Ga, . PMID: 40868149 [PubMed - in process]
	Unexpectedly Low Rate of Metastasis and Death Among Patients Treated for Uveal Melanoma with Brachytherapy, Vitrectomy, and Silicone Oil. Cancers (Basel) Rivas A, Samlowski W, McCannel TA. PMID: 40867312 [PubMed - in process]
	Confronting Melanoma Radioresistance: Mechanisms and Therapeutic Strategies. Cancers (Basel) Gorodetska I, Schulz A, Behre G, Dubrovska A. PMID: 40867277 [PubMed - in process]

Articles 1 - 20 / 43357

Page 1 of 2168



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy